Highlights from the 20-23 June 2022 CHMP meeting

24 June 2022 - EMA’s CHMP recommended nine medicines for approval at its June 2022 meeting. ...

Read more →

NICE opts to reject Acorda’s MS drug Fampyra

22 June 2022 - NICE has announced its decision to reject Fampyra – also known as fampridine – for use ...

Read more →

MSAC publishes agenda for October 2022 ESC meeting

22 June 2022 - The MSAC Secretariat has published a list of applications scheduled to be considered by the ESC on ...

Read more →

Slow release potassium bicarbonate–potassium citrate for treating distal renal tubular acidosis

21 June 2022 - The Department of Health and Social Care has asked NICE to produce guidance on using slow-release ...

Read more →

Tebentafusp for treating advanced (unresectable or metastatic) uveal melanoma

21 June 2022 - The Department of Health and Social Care has asked NICE to produce guidance on using tebentafusp ...

Read more →

EMA publishes agenda for 20-23 June 2022 CHMP meeting

20 June 2022 - The EMA has published a draft agenda for this week's CHMP meeting. ...

Read more →

Zeposia is included in the high-cost protection with limitation

17 June 2022 - Zeposia (ozanimod) is included in the high-cost protection with limited subsidy from 17 June 2022.  ...

Read more →

Givlaari is included in the high-cost protection with limitation

17 June 2022 - Givlaari (givosiran) is included in the high-cost protection with limited subsidy to reduce attacks in patients with ...

Read more →

EU HTA regulation: international preparatory meeting in Cologne

17 June 2022 - At the invitation of IQWiG, 41 envoys from European HTA organisations and two from the EU ...

Read more →

Current issues in health technology assessment of cancer therapies: a survey of stakeholders and opinion leaders in Australia

17 June 2022 - The aim of this study was to find ways of bridging the gap in opinions concerning health ...

Read more →

NICE recommends new targeted treatment for early breast cancer

16 June 2022 - NICE has provisionally approved a new treatment for early breast cancer that it says will benefit ...

Read more →

Outcomes of the May 2022 PBAC intracycle meeting

17 June 2022 - The outcomes from the May 2022 PBAC meeting are now available. ...

Read more →

Public consultation: draft 2022-23 cost recovery implementation statement for listing medicines on the PBS and designated vaccines on the NIP

17 June 2022 - Consultation on the content of the draft 2022-23 Cost Recovery Implementation Statement (CRIS) for listing medicines ...

Read more →

Core network partners announced for CADTH’s post-market drug evaluation network

10 June 2022 - CADTH is pleased to announce the four successful core network partners of its inaugural post-market drug ...

Read more →

New treatment to increase the chances of a successful kidney transplant recommended by NICE

16 June 2022 - A new treatment that increases the chance of a successful kidney transplant has been recommended by ...

Read more →